Human papilHomavirus type 16 E7 is considered to be a major viral oncoprotein playing an important role(s) in cervical cancers. E7 protein was shown to bind to the protein product of the retinoblastoma gene (RB), while simian virus 40 large T and adenovirus ElA were also shown to possess binding activity to RB protein. The RB protein is a cell cycle regulator that is highly phosphorylated specifically in S, G2, and M, whereas it is underphosphorylated in Go and G1. Recently, large T was demonstrated to bind preferentially to the underphosphorylated RB protein, which is considered to be an active form restricting cell proliferation. However, it is not known whether E7 can bind to phosphorylated RB protein. We (5, 13, 14) . DNA has the ability to transform established rodent cell lines (47, 52) and to immortalize primary rodent or human keratinocytes (39, 41) . The HPVs are therefore believed to be involved in the development of cervical cancers. The viral DNA integrated into the genome of cancer cells is truncated to various degrees. However, E6 and E7 open reading frames are consistently retained and expressed as mRNA or proteins (2, 25, 43, 44, 46) . Molecular genetic studies to localize the transforming activities of HPV revealed that the E7 region is the major transforming gene (38) . Recent studies suggest that not only the E7 but also the E6 region is necessary for the transformation of primary human keratinocytes (35).
underphosphorylated RB protein, which is considered to be an active form restricting cell proliferation. However, it is not known whether E7 can bind to phosphorylated RB protein. We successfully purified large quantities of unfused human papillomavirus type 16 E7 protein expressed in Escherichia coli by using a T7 promoter-T7 RNA polymerase system. The purified E7 protein was demonstrated to bind preferentially to the underphosphorylated RB protein.
More than 60 types of human papillomaviruses (HPVs) have been reported. Among them, HPV types 16 (HPV-16), 18, 31, 33, 35, 39, 45, 51, 52 , and 56 are frequently found in cervical cancer tissues or cell lines (5, 13, 14) . DNA has the ability to transform established rodent cell lines (47, 52) and to immortalize primary rodent or human keratinocytes (39, 41) . The HPVs are therefore believed to be involved in the development of cervical cancers. The viral DNA integrated into the genome of cancer cells is truncated to various degrees. However, E6 and E7 open reading frames are consistently retained and expressed as mRNA or proteins (2, 25, 43, 44, 46) . Molecular genetic studies to localize the transforming activities of HPV revealed that the E7 region is the major transforming gene (38) . Recent studies suggest that not only the E7 but also the E6 region is necessary for the transformation of primary human keratinocytes (35) .
The retinoblastoma gene (RB) was deleted or mutated in many types of tumor cells, including retinoblastomas (17, 18, 30) , osteosarcomas (17) , small-cell lung carcinomas (21, 53) , breast cancers (29) , bladder carcinomas (22) , prostate carcinomas (4) , and leukemias (9) . The RB gene was reported to restrict cell proliferation (4, 23) . The loss of normal activity of the RB gene is consequently believed to play a key role in the generation of the cancers. It was reported that E7 proteins of HPVs could bind to the RB gene product, the RB protein (3, 15, 19, 36) . The transforming proteins of adenovirus and simian virus 40 (SV40), ElA and large T, respectively, also associated with the RB protein (11, 50) . These observations suggest that the formation of complexes of the RB protein and the transforming proteins of the DNA tumor viruses may cause the loss or alteration of the biological function of the RB gene product and allow the cells to proliferate uncontrollably (20 (3, 26, 43, 44) . We report here the successful production of unfused HPV-16 E7 protein in Escherichia coli and the purification of the protein to homogeneity. Using E7-coupled Sepharose gels, we examine the ability of E7 protein to bind to the highly phosphorylated and the underphosphorylated forms of the RB protein.
MATERIALS AND METHODS
Construction of expression vector. An NdeI-HindIII fragment of T7 promoter expression vector pGEMEXTM-1 (Promega) was substituted for an EcoT22I-NcoI fragment of HPV-16 (nucleotide positions 563 to 867) (42) by using a synthetic single-strand oligonucleotide linker, 5'-TATGCA-3', which connected the translation initiation site of the vector and the first ATG codon of the E7 open reading frame in frame (Fig. 1) (27) . Mutations were introduced into E7 sequence cloned into M13mpl8 phage vector with 21-mer synthetic oligonucleotides, and the generated mutations were examined by the dideoxy-chain termination sequencing method (40) . Leu raphy, ammonium sulfate precipitation, and Sephadex G-75 chromatography (Fig. 2, lane 3) . Its first 20 amino-terminal residues, determined by Edman degradation, were identical with those of the E7 protein predicted by the nucleotide sequence (42) . (Fig. 3, lane 3) . A similar band was also detected in the extract from SKG-IIIa cells (lane 4) but not in the extract from NIH 3T3 cells (lane 2). SKG-IIIa is a cervical cancer cell line that contains a single copy of HPV-16 DNA per cell (48) . The mobility of the purified E7 protein (lane 1) was the same as those of the bands that were effectively recognized by the anti-recombinant E7 serum, and the intensities of these bands markedly decreased when the serum had been preincubated with excessive amounts of the purified E7 protein. On the basis of these findings, we conclude that the 19,000-Da protein was HPV-16 E7 protein. Both the purified and the SKG-IIIaderived E7 proteins showed similar intensities in the immunoblot analysis (Fig. 3, lanes 1 and 4) , in which the total amounts of loaded proteins were 0.1 ng and 80 ,ug, respectively. The content of E7 protein in SKG-Illa cells is consequently estimated as about 0.0001% of the total cellular protein if there is no significant difference in the affinity of the anti-E7 serum to both of the E7 proteins. We could not detect any DNA-binding activities for the purified E7 protein when it was examined by DNA-cellulose chromatography or by a gel retardation assay using a DNA fragment corresponding to the HPV-16 long control region or the adenovirus E2 promoter.
RB-binding properties of HPV-16 E7 protein. The purified E7 protein was chemically coupled with Sepharose 4B gel beads and used for a novel assay to determine the E7-binding activity of cellular proteins. During incubation with E7-Sepharose, E7-binding proteins were associated with E7 and were therefore easily precipitated together with the gel. For the source of RB protein, we chose HL60 cells, a human leukemia cell line in which RB protein was reported to be highly phosphorylated under the usual culture conditions, whereas it was converted to the underphosphorylated form when cells were cultured in the presence of TPA or dimethyl sulfoxide (1, 8, 34) .
The extract from HL60 cells cultured in the presence or absence of TPA was incubated with E7-Sepharose prior to the analysis of coprecipitated proteins by immunoblotting with PGM3-245, an anti-RB monoclonal antibody that could recognize both highly phosphorylated and underphosphorylated forms of RB protein (32) . The phosphorylation status of RB protein could be easily examined by SDS-PAGE, in which the mobility of the RB protein shifted according to the extent of phosphorylation (7, 8, 12) . We performed 35S-and 32P-labeling experiments showing that RB proteins in HL60 cells before and after the cells were cultured in the presence of TPA were really highly phosphorylated and underphosphorylated, respectively, under culture conditions essentially equal to those for the E7-Sepharose precipitation assay (Fig. 4) . In the absence of TPA, the RB protein in the cells was highly phosphorylated to various degrees and showed broad and slowly migrating bands (ppllO-RB) (Fig. 4, lanes  1 and 3 and Fig. 5, lane 1) . In the presence of TPA, by contrast, most of the RB protein was converted to the most rapidly migrating form (p105-RB) or the underphosphorylated form (Fig. 4, lanes 2 and 4 and Fig. 5, lane 4) . When E7-Sepharose was incubated with the extract from proliferating HL60 cells, most of the RB protein, which was the highly phosphorylated form, could not bind to the gel (Fig. 5,  lane 3) and remained in the liquid phase (Fig. 5, lane 2) . On the other hand, when the cells were treated with TPA, most of the RB protein was converted to the underphosphorylated form, which was preferentially and stably associated with the E7-Sepharose and not released from the gel until boiled under denaturing conditions (Fig. 5, lane 6) . The residual highly phosphorylated RB protein did not bind to the gel (Fig. 5, lane 5) as was shown to be the case for the TPA-untreated cells. The molecular masses (105 to 110 kDa) of the bands recognized by PMG3-245 anti-RB antibody in our experiments were identical to those demonstrated for RB proteins by several other laboratories (7, 8, 11, 12, 32) and compatible with the molecular mass deduced from its nucleotide sequence. In our preliminary experiments with PMG3-245 antibody, corresponding bands were not detected in the retinoblastoma cell line Y79, which expresses no normal RB protein (31) (data not shown). The nature of the additional faster migrating bands shown in Fig. 4 , lanes 1 and 2 and in Fig. 5, lanes 1 and 2 is SV40 large T contain highly homologous sequences corresponding to HPV-16 E7 amino acids 4 to 37, which are considered essential for both RB-binding and transforming activities of HPV-16 E7 protein (Fig. 6) (3, 16, 26, 36, 49) . A point mutation substituting leucine 13 for serine was introduced into HPV-16 E7, and the expressed protein was purified and immobilized to Sepharose. The same quantities of wild-type protein and leucine-substituted E7 protein were coupled to the gel under the same conditions. Both proteins had the same solubility, SDS-PAGE mobility, and reactivity against anti-E7 antiserum. The resulting gel was incubated with the extract from HL60 cells cultured in the absence of TPA prior to the analysis of coprecipitated proteins by immunoblotting with anti-RB monoclonal antibody PMG3-245 (Fig. 7) . About half of the highly phosphorylated form of RB protein was coprecipitated with the mutated E7-Sepharose (Fig. 7, lane 5) but not with the wild-type E7-Sepharose (Fig. 7, lane 3) . The underphosphorylated RB protein from TPA-treated cells also bound to the leucine-substituted E7-Sepharose in a manner similar to that in which it bound to the wild-type E7-Sepharose (data not shown). A mutation substituting cysteine 24 in conserved domain 2 was reported to reduce the binding affinity to RB protein (3, 26, 36) . We prepared cysteine 24-substituted E7 for glycine and coupled it to Sepharose. The underphosphorylated RB protein bound less efficiently to the cysteine-mutated E7-Sepharose (unpublished data).
DISCUSSION
We have described here the purification and the RBbinding activity of the unfused HPV-16 E7 protein expressed in E. coli. This is the first report describing the purification of E7 protein in unfused soluble forms. In SDS-PAGE analysis, both cell line-derived and bacterially expressed unfused E7 proteins migrated to the same position, corresponding to 19,000 Da (Fig. 3) , which is discrepant with the molecular mass of 11,000 Da deduced from its amino acid sequence. The reasons for this aberrant mobility are not clear. E7 protein was reported to be a small nuclear phosphoprotein containing one possible zinc finger structure (19, 45, 49) and to be capable of transactivating the adenovirus E2 promoter (38) . The cellular content of the E7 protein was only 0.0001% (Fig. 3) (32, 33) , whereas ElA was suggested to bind both highly phosphorylated and underphosphorylated RB protein (51) .
We have demonstrated here that the purified HPV-16 E7 protein could bind preferentially to the underphosphorylated RB protein but not to the highly phosphorylated form (Fig.  5) . It was shown that all of the RB protein was underphosphorylated in Go or G1 phase (7, 8, 12) . At the G1/S boundary, the RB protein was converted to the highly phosphorylated form, possibly by cdc2 kinase (10) . In M and at the M/G1 boundary, the RB protein completely lost its phosphate groups. HL60 cells induced to differentiate showed a striking conversion of RB protein from the highly phosphorylated to the underphosphorylated form (Fig. 4) (1,  8, 34 ). These observations suggest that E7 protein functions to inactivate or modulate the underphosphorylated RB protein that shuts down the entrance of cells in the cycle at the G1/S boundary.
We introduced a novel assay using E7-Sepharose gel as a ligand for the binding of RB protein. Our single-step precipitation method has some advantages over the commonly used procedures with in vitro-translated E7 and/or RB proteins (3, 15, 19, 26, 36) ; it is nonradioisotopic, easy and rapid, and free of the problems associated with the use of antibodies that may carry low affinity or cross-reactivity. As is well known, the RB protein translated in vitro is smaller than the RB protein expressed in cells, and therefore some of its natural properties may be lost or altered.
HPV (Fig. 6 ). These sequences are well conserved among not only the oncoproteins of these DNA tumor viruses but also E7 proteins of both malignant and benign types of HPV, suggesting that these structures carry very important functions common in the viruses. Indeed, RB protein-binding activity was located in these regions of E7, ElA, or large T (3, 11, 36, 51) . Both ElA conserved domains 1 and 2 were shown to be required for the RB binding of ElA protein (51) , whereas no significant decrease in RB-binding affinity was observed with E7 protein that contained a mutation in the region homologous to domain 1 (36) . Within the corresponding region of HPV-16 E7 protein, however, transforming activity for human fibroblasts was mapped at an amino acid, leucine 13 (49) , which is conserved even among all of the other sequenced HPVs, including types la, Sc, 6b, 8, 11, 18, 31, and 33. We have shown here that this leucine of E7 protein plays an important role in distinguishing the underphosphorylated RB from the highly phosphorylated RB protein under the conditions we used. The leucine corresponding to leucine 13 of HPV-16 E7 is conserved in large T but not in ElA proteins. It is quite interesting that ElA protein but not large T was reported to bind to both the highly phosphorylated and the underphosphorylated RB protein (51) . The relationship between the transforming activities of E7 protein and the ability to bind to highly phosphorylated and/or underphosphorylated RB protein remains to be clarified.
It was reported that cysteine 24 in domain 2 plays an important role in the binding of E7 to RB protein (3, 26, 36) .
With the cysteine 24-substituted E7-Sepharose, we confirmed the observation showing decreased affinity of RB protein to this type of mutated E7 protein. In any event, E7-coupled Sepharose will be a valuable tool to identify other cellular proteins that interact with E7 protein and also to understand the molecular interaction between E7 and RB proteins.
